Trial intelligence / Profile preview

Aspirin and dipyridamole effect on primary patency of arteriovenous grafts

TCTR20160920003Phase 4Completed

Sponsor
Dr Hasan Ravari
Start
Sep 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aspirin, dipyridamole in Arteriovenous Graft Occlusion, sponsored by Dr Hasan Ravari. Started Sep 2015; status: completed.

02

Drugs

aspirindipyridamole
03

Conditions

Arteriovenous Graft Occlusion

Beyond the preview

Go deeper on TCTR20160920003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160920003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call